Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Binimetinib +3 More for Melanoma
Recruiting1 awardPhase 1 & 2
Pittsburgh, Pennsylvania
This trial is testing a combination of three or four drugs to see if they are more effective at treating melanoma than two drugs. The three drugs are a BRAF inhibitor, a MEK inhibitor, and a immunotherapy drug. The fourth drug is another immunotherapy drug.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service